HMG20A and colorectal carcinoma: However, these results imply that the overexpression of EZH2 and under-expression of FOXO1 are the main characteristics of CRC drug resistance and metastasis, with SFMBT1 and HMG20A identified as possible targets for therapeutic agents to increase drug resistance.